Management of renovascular hypertension.

Curr Opin Cardiol

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.

Published: November 2020

Purpose Of Review: Renovascular occlusive disease remains a common cause of resistant and rapidly progressive hypertension. The present review summarizes current practice regarding management of renovascular hypertension (RVH).

Recent Findings: Current data using blood oxygen level dependent MR emphasize the tolerance of the kidney to moderate reductions in blood flow and the efficacy of antihypertensive drug therapy for many individuals. Prospective trials have failed to identify benefits of revascularization for moderate disease, either regarding blood pressure or renal function. Antihypertensive drug therapy including renin-angiotensin system blockade is central to management of RVH. Recent and ongoing observational studies report important improvements after revascularization regarding blood pressure, management of refractory or 'flash' pulmonary edema, and survival in specific 'high risk' clinical populations not included in randomized trials. Research directions underscore the role of adjunctive measures, including mitochondrial protection, therapeutic angiogenesis, and cell-based regenerative repair to protect kidney function in RVH.

Summary: Clinicians should recognize the potential for disease progression to threaten renal function with severe and prolonged renal ischemia. Improved patient selection for true resistant hypertension with RVH and 'high-risk' clinical manifestations is critical to identify those likely to benefit from renal revascularization.

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCO.0000000000000790DOI Listing

Publication Analysis

Top Keywords

management renovascular
8
renovascular hypertension
8
antihypertensive drug
8
drug therapy
8
blood pressure
8
renal function
8
management
4
hypertension
4
hypertension purpose
4
purpose review
4

Similar Publications

Risk of severe maternal morbidity and mortality among pregnant patients with chronic kidney disease: Renal disease and severe maternal morbidity.

Am J Obstet Gynecol MFM

January 2025

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, Ohio 45267, USA. Electronic address:

Background: Chronic kidney disease is a significant cause of adverse obstetric outcomes. However, there are few studies assessing the risk of severe maternal morbidity and mortality among patients with chronic kidney disease and no studies assessing the association between individual indicators of severe maternal morbidity and chronic kidney disease.

Objective: To evaluate the risk of severe maternal morbidity and mortality among pregnant patients with chronic kidney disease.

View Article and Find Full Text PDF

Arterial hypertension in young adults, which includes patients between 19 and 40 years of age, has been increasing in recent years and is associated with a significantly higher risk of target organ damage and short-term mortality. It has been reported that up to 10% of these cases are due to a potentially reversible secondary cause, mainly of endocrine (primary aldosteronism, Cushing's syndrome, and pheochromocytoma/paraganglioma), renal (renovascular hypertension due to fibromuscular dysplasia and renal parenchymal disease), or cardiac (coarctation of the aorta) origin. It is recommended to rule out a secondary cause of high blood pressure (BP) in those patients with early onset of grade 2 or 3 hypertension, acute worsening of previously controlled hypertension, resistant hypertension, hypertensive emergency, severe target organ damage disproportionate to the grade of hypertension, or in the face of clinical or biochemical characteristics suggestive of a secondary cause of hypertension.

View Article and Find Full Text PDF

Renal Infarction in a Newly Diagnosed Atrial Fibrillation Patient.

Cureus

November 2024

Emergency Medicine, St. Mary's Hospital, Isle of Wight NHS Trust, Isle of Wight, GBR.

Renal infarction is a rare but potentially serious condition, often misdiagnosed due to its non-specific presentation, which mimics conditions such as nephrolithiasis and pyelonephritis. Discussed in this case report is a 68-year-old woman who presented to an emergency department with two weeks of worsening left flank pain. She was found to have a new diagnosis of atrial fibrillation (AF) on electrocardiogram (ECG) and CT findings revealing renal infarction.

View Article and Find Full Text PDF
Article Synopsis
  • Renal artery stenosis (RAS) and mid-aortic syndrome (MAS) are important but often overlooked causes of high blood pressure in children, with RAS involving the narrowing of renal arteries and MAS affecting the abdominal aorta and associated vessels.
  • These conditions can arise from genetic issues and other factors like fibromuscular dysplasia and Takayasu arteritis, making their symptoms complicated and hard to diagnose despite improved imaging techniques.
  • Treatment varies from medications that only partially control blood pressure to more invasive options like angioplasty and surgery, and the article emphasizes the need for a multidisciplinary approach and early detection to improve treatment outcomes for affected children.
View Article and Find Full Text PDF

Idiopathic congenital abdominal aortic aneurysm (AAA) is rare, with only a few cases reported in the literature. We present a case of a 3-year-old girl with a fusiform AAA measuring 19 mm in segments 4 and 5, associated with renal artery stenosis and severe hypertension. She was treated with three antihypertensive medications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!